Pfizer: Growth Hormone

Projects submitted may include:

• Morbidities in growth disorders
• Strategies to evaluate and treat growth disorders including Quality of Life and Patient Reported Outcomes
• Comparative pathophysiology of daily vs long-acting growth hormone
• Evaluation of adherence of daily and long-acting growth hormone treatment
• Novel strategies to address current unmet medical needs in short stature management which could be addressed with long-acting growth hormone treatment
• Comparison of clinical effects of daily vs long-acting growth hormone

Funding: up to $150,000.

https://cdn.pfizer.com/pfizercom/2022-05/GMG_2022-RD-G_GrowthHormoneResearch.pdf?OBCLa5eGRczYZy98biNYYlflgVvGIpjq=

https://www.pfizer.com/purpose/independent-grants/competitive-grants